1998
DOI: 10.1001/archopht.116.1.69
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

An Intravitreal Sustained-Release Triamcinolone and 5-Fluorouracil Codrug in the Treatment of Experimental Proliferative Vitreoretinopathy

Search citation statements

Order By: Relevance

Paper Sections

Select...
81
11
8
0

Citation Types

0
49
1
7

Year Published

Range
1998
1998
2026
2026

Publication Types

Select...
85
10
3
1

Relationship

1
98

Authors

Journals

citations

Cited by 99 publications

(57 citation statements)
references

References 19 publications

0
49
1
7
Order By: Relevance
How this paper cites the one you are viewing
“…These include embolic retinal artery occlusion and accidental penetration or perforation of the globe. [16][17][18][19] The findings from our study neither advocate nor support the use of intravitreal corticosteroids for the treatment of retinal neovascularization or any other condition. Intravitreal triamcinolone has been studied in animals for retinal neovascularization and proliferative vitreoretinopathy.…”
Section: Comment
contrasting
confidence: 80%